Partilhar
Informação da revista
Editorial
Open letter to our reviewers: Justice is needed!
Helena Donato, Nuno Cardim
Rev Port Cardiol. 2021;40:1-3
Open access
Artigos originais
Relationships between paroxysmal atrial fibrillation, total oxidant status, and DNA damage
Mustafa Begenc Tascanov, Zulkif Tanriverdi, Fatih Gungoren, Feyzullah Besli, Muslihittin Emre Erkus, İbrahim Halil Altiparmak, Ataman Gonel, Ismail Koyuncu, Recep Demirbag
Rev Port Cardiol. 2021;40:5-10
Open access
Artigos Originais
Comentário editorial
Oxidative stress and atrial fibrillation – association or causation?
Francisco Moscoso Costa, Fu Siong Ng
Rev Port Cardiol. 2021;40:11-2
Open access
Cardiac rehabilitation in older patients: Indication or limitation?
Marta Braga, Helena Nascimento, Roberto Pinto, Paulo Araújo, Alzira Nunes, Joana Rodrigues, Vítor Araújo, Fernando Parada-Pereira, ... Afonso Rocha
Rev Port Cardiol. 2021;40:13-20
Open access
Artigos Originais
Comentário editorial
Os idosos são candidatos prioritários na reabilitação cardíaca
Miguel Mendes
Rev Port Cardiol. 2021;40:21-3
Open access
Coronary artery calcium scoring and cardiovascular risk reclassification in patients undergoing coronary computed tomography angiography
Daniel Matos, António Miguel Ferreira, Pedro de Araújo Gonçalves, Francisco Gama, Pedro Freitas, Sara Guerreiro, Gonçalo Cardoso, António Tralhão, ... Miguel Mendes
Rev Port Cardiol. 2021;40:25-30
Open access
Artigos Originais
Comentário editorial
Prime time for coronary calcium scoring: It should come, but will it?
Nuno Bettencourt
Rev Port Cardiol. 2021;40:31-2
Open access
Brugada syndrome: Eligibility for subcutaneous implantable cardioverter-defibrillator after exercise stress test
Pedro von Hafe, Bebiana Faria, Geraldo Dias, Filipa Cardoso, Maria José Alves, Assunção Alves, Bernardete Rodrigues, Sílvia Ribeiro, ... António Lourenço
Rev Port Cardiol. 2021;40:33-8
Open access
Artigos Originais
Comentário editorial
The variability of the electrocardiogram in Brugada syndrome: Implications for subcutaneous implantable cardioverter-defibrillator candidacy
Pedro Brugada
Rev Port Cardiol. 2021;40:39-40
Open access
Documento de Consenso sobre a realização de ressonância magnética em doentes com dispositivos cardíacos electrónicos implantados
Ana G. Almeida, Natália António, Carla Saraiva, António Miguel Ferreira, António Hipólito Reis, Hugo Marques, Nuno Dias Ferreira, Mário Oliveira
Rev Port Cardiol. 2021;40:41-52
Open access
Artigos Originais
Comentário editorial
Breaking down the barriers: Re-evaluating risk of MRI in patients with cardiac implantable electronic devices via collaborative practice
João B. Augusto, Charlotte Manisty
Rev Port Cardiol. 2021;40:53-5
Open access
Pequena comunicação
Invasive pulmonary aspergillosis in heart transplant recipients: Is mortality decreasing?
Eduardo Flores-Umanzor, Juan Betuel Ivey-Miranda, Margarida Pujol-Lopez, Pedro Cepas-Guillen, Andrea Fernandez-Valledor, Guillen Caldentey, Marta Farrero, Ana García, ... María A. Castel Md
Rev Port Cardiol. 2021;40:57-61
Open access
Caso clínico
Quadricuspid aortic valve with a hidden left ostium: Case report and literature review
Filipe R. Soares, Carlos Branco, Gonçalo F. Coutinho, David Prieto, Manuel J. Antunes
Rev Port Cardiol. 2021;40:63.e1-63.e5
Open access
Imagem em cardiologia
Basal type ‘broken heart’ in a postpartum woman: Utility of speckle tracking echocardiography
Nikolaos Miaris, Nearchos Kasinos, Archontoula Michelongona, Afroditi Konstantara, Dimitrios Barmpagiannis, Antonios Destounis, Panagiotis Zachos, Evangelia Nyktari, ... Evangelos Pisimisis
Rev Port Cardiol. 2021;40:65-7
Open access
Carta ao editor
ST-elevation acute coronary syndrome without obstructive coronary disease in a COVID-19 patient
Tânia Proença, Mariana Paiva, Ricardo Alves Pinto, Miguel Martins Carvalho, Ricardo Lopes, Filipe Macedo
Rev Port Cardiol. 2021;40:69-70
Open access
Artigo aberto
Conteúdo especial sobre COVID-19
- High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal
- Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitus
- Percutaneous coronary intervention in chronic total occlusions: Should it be avoided in type 2 diabetic patients?
- RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.